… , more than 70% of pregnant women with antiphospholipid syndrome will deliver a viable live
… - text of each patient with the syndrome and to outline the risks of pregnancy and treatment. …

… pregnancy losses; however the optimal treatment of patients is … on the treatment of APS in
pregnancy. A questionnaire that … The consensus was that treatment for APS pregnant patients …

… autoimmune disorder with severe life-threatening complications shown during pregnancy.
In this … compare the pregnancy outcomes (both maternal and fetal) in patients with APS. …

… pregnancies in 54 women with antiphospholipid syndrome who were treated during pregnancy
… Patients with successful treated pregnancies had fewer previous fetal deaths than those …

… Only singleton pregnancies with primary antiphospholipid syndrome were included. The
primary outcome was live birth, defined as any delivery of a live infant after 22 weeks …

… used to identify factors associated with adverse pregnancy outcomes (fetal loss, premature
… 64 pregnancies in 59 patients with APS (age, 32.3 ± 4.3 years) and 256 pregnancies in 256 …

… In retrospective studies of pregnant patients with aPL and or APS, we and others showed
that HCQ is a candidate for preventing aPL-related adverse pregnancy outcomes [10], [11]. …

… patients to fetal loss, placental insufficiency and preeclampsia [44]. Another subgroup
identified by this meta-analysis as high-risk of pregnancy complications consists of patients with …

… for the patient and … patient's individual clinical circumstances. This review focuses on the
management of women with aPL or APS who are pregnant or attempting to become pregnant. …

… for pregnancy outcome known to the authors. We selected ‘antiphospholipid syndrome’ as
… We had 548 results with the combination ‘antiphospholipid syndrome’ AND ‘pregnancy risk …